BAJAJ FINSERV DIRECT LIMITED

Our Products

Loans

Cards

Insurance

Investment

Stock Market

Electronics Mall

CIBIL Score

Knowledge Centre

Calculators

Corona Remedies Ltd IPO Subscription Status

Anshika

Learn how Corona Remedies Ltd’s IPO performed, including subscription data, key dates, price band details, and steps to apply using ASBA or UPI.

Corona Remedies Ltd launched its IPO on 8 December 2025, aiming to strengthen its capital base and support strategic growth initiatives within India’s pharmaceutical sector. The company is engaged in the development and distribution of branded formulations across therapeutic categories such as cardiology, diabetology, dermatology, and pain management. With a well-established domestic presence, the IPO has garnered attention from investors seeking exposure to healthcare-driven opportunities. The public issue size stands at ₹655.37 Cr, offered through a book-building structure with defined pricing parameters.

Corona Remedies Ltd IPO Subscription Status

Day 1 activity reflected growing interest from retail and non-institutional investors, while institutional investors were yet to participate. The following section outlines the Day 1 subscription levels.

Day 1 Subscription Status (8 December 2025)

The overall subscription for the Corona Remedies IPO stood at 0.47× by the end of the first day. Retail and other non-institutional bids formed the majority of early submissions.

Investor Category Subscription (Times)

Qualified Institutional Buyers (QIB)

0.00×

Retail Individual Investors (RII)

0.70×

Non-Institutional Investors (NII)

0.52×

Others

1.10×

Total

0.47×

The response reflects strong interest in certain investor segments, with momentum expected to build over the subscription window.

Day 2 Subscription Status (9 December 2025)

Corona Remedies Ltd saw a substantial jump in bidding activity by Day 2, with strong interest from NIIs and RRIs as depicted in your images.

Investor Category Subscription (Times)

Qualified Institutional Buyers (QIB)

0.81×

Retail Individual Investors (RII)

5.29×

Non-Institutional Investors (NII)

16.84×

Others

3.43×

Total

6.44×

Corona Remedies shows robust traction, especially from NIIs, lifting overall demand on Day 2.

Corona Remedies Ltd IPO Price Band and Lot Size

The pricing overview for the offer is summarised in the following table:

Particulars Details

Price Band

₹1,008 – ₹1,062 per share

Lot Size

14 shares

Minimum Investment (Retail)

Approx. ₹14,112

Face Value

₹10 per share

Issue Size

₹655.37 Cr

The pricing reflects the company’s established market position and product portfolio.

For detailed insights about the company, issue particulars, and the latest updates, visit the Corona Remedies IPO on Bajaj Markets.

Corona Remedies Ltd IPO Open Date, Close Date, and Allotment Date

Below is a structured table summarising the IPO timeline:

Event Date Details

IPO Open Date

8 December 2025

Subscription opens

IPO Close Date

10 December 2025

Last day to apply

Basis of Allotment

12 December 2025

Allotment finalisation

Refunds Initiation

12 December 2025

Refunds begin

Credit of Shares to Demat

12 December 2025

Shares credited

Listing Date

15 December 2025

Expected listing on NSE & BSE

Note: These dates represent procedural milestones based on publicly available data and are intended for informational purposes only.

How to Apply for Corona Remedies Ltd IPO

Investors can apply for the Corona Remedies Ltd IPO using either the ASBA facility through your bank or via UPI on broker platforms.

Through ASBA (Net Banking)

This is a convenient and secure method where your application amount stays blocked until shares are allotted.

  1. Log in to your internet banking account.

  2. Go to the ‘Investments’ or ‘IPO Application’ section.

  3. Select ‘Corona Remedies Ltd IPO’ from the available list.

  4. Enter your preferred bid quantity and price.

  5. Confirm and submit your application.

  6. The bid amount will remain blocked in your account until allotment.

  7. Upon allotment, the amount will be debited, and shares credited to your Demat account.

Through UPI via Broker Platforms

You can apply using UPI through your stockbroker’s or financial marketplace’s online platform.

  1. Log in to your trading account or Demat account on your broker’s platform or financial marketplace.

  2. Navigate to the IPO section and select ‘Corona Remedies Ltd IPO’.

  3. Enter your application details including number of lots and price.

  4. Provide your UPI ID linked to your bank account.

  5. Approve the UPI mandate request on your UPI app (like BHIM, Google Pay, or PhonePe).

  6. Funds will be debited only upon share allotment.

  7. Once allotted, shares will be credited directly to your Demat account.

Check other upcoming ipo’s here : Upcoming IPO

Disclaimer

The information provided above is based on publicly available data from reliable financial news and market sources. Investors are advised to verify figures and consult financial experts before making investment decisions. Market conditions and subscription numbers are subject to change during the IPO window.

Sources

 

  • LiveMint — IPO News and Updates, https://www.livemint.com/market/ipo

  • Economic Times — IPO News: Latest IPO News, Upcoming IPO, https://economictimes.indiatimes.com/markets/ipo

  • Financial Express — IPO News, https://www.financialexpress.com/market/ipo-news/

  • NDTV Profit — IPOs, https://www.ndtvprofit.com/ipos

  • Business Today — IPO Corner: Latest IPO News & Analysis, https://www.businesstoday.in/markets/ipo-corner

Hi! I’m Anshika
Financial Content Specialist

Anshika brings 7+ years of experience in stock market operations, project management, and investment banking processes. She has led cross-functional initiatives and managed the delivery of digital investment portals. Backed by industry certifications, she holds a strong foundation in financial operations. With deep expertise in capital markets, she connects strategy with execution, ensuring compliance to deliver impact. 

Home
Steal Deals
CIBIL Score
Free Cibil
Accounts
Explore